|
|
 |
Hybrid Capture® 2 High-Risk HPV DNA Test® | | | General Information | |
| Vendor | | Digene Corporation | | Item | | Hybrid Capture® 2 High-Risk HPV DNA Test® | | Features | | - The Digene HPV Test offers the laboratory optimum clinical sensitivity for patient risk assessment
| | Approval | | US FDA | | Product Number | | 5199-1220 | | Analysis Time | | Inquire | | Sample | | Cervical specimens that can be tested with the Digene tests include specimens collected with the Digene Cervical Sampler/DNA Collection Device, biopsies collected in Specimen Transport Medium, and specimens collected using a broom type collection device and placed in Cytyc ThinPrep Pap Test PreservCyt Solution. | | Sensitivity | | Greater than 96% for the detection of high–grade CIN and cancer when performed with cytology | | Instrumentation Needed | | Inquire | | Specificity | | Inquire | | Test Method | | Signal–amplified, nucleic acid test | | Number of Tests | | There are 96 tests in one hc2 High-Risk HPV DNA Test kit | | Pricing |  | Inquire | | Financing | | To finance this purchase click here (U.S. customers only) |
| | Related Content | |
| | Product Description | |
| An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68 in Cervical Specimens. | |
| Digene Corporation | | Customer Service: (800) DIGENE–1 | | Web site: http://www.digene.com | | Please mention Medcompare.com when you contact the vendor. |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
